Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells

European Journal of Pharmacology

Volumn 566, Issue 1-3, 2007, Pages 1-10

  Tsuneki, Hiroshi ^a   Sekizaki, Naoto ^a   Suzuki, Takashi ^a   Kobayashi, Shinjiro ^b   Wada, Tsutomu ^a   Okamoto, Tadashi ^c   Kimura, Ikuko ^a   Sasaoka, Toshiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Adhesion; Apoptosis; Coenzyme Q10; Diabetes; Endothelial cell; Glucose

Indexed keywords

CASPASE 3; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 2; REACTIVE OXYGEN METABOLITE; UBIDECARENONE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; UBIQUINONE; VITAMIN;

APOPTOSIS; ARTICLE; BIOCHEMICAL COMPOSITION; CELL ADHESION; CELL STRAIN U937; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; UPREGULATION; CELL CULTURE; COENZYME; CYTOLOGY; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELLS, CULTURED; COENZYMES; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; UBIQUINONE; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1; VITAMINS;

EID: 34249008430     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.03.006     Document Type: Article

References (48)

1. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191-203
2. Boyle J.J. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr. Vasc. Pharmacol. 3 (2005) 63-68
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
4. Calles-Escandon J., and Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev. 22 (2001) 36-52
5. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26 (2003) 1589-1596
6. Chagan L., Ioselovich A., Asherova L., and Cheng J.W. Use of alternative pharmacotherapy in management of cardiovascular diseases. Am. J. Manag. Care 8 (2002) 270-285
7. 10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis' Q. J. Med. 97 (2004) 537-548
8. Cosentino F., Eto M., De Paolis P., van der Loo B., Bachschmid M., Ullrich V., Kouroedov A., Delli Gatti C., Joch H., Volpe M., and Lüscher T.F. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107 (2003) 1017-1023
9. 10. J. Am. Coll. Nutr. 20 (2001) 591-598
10. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., and Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 347 (1996) 444-445
11. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., and Vanhoutte P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130 (2000) 963-974
12. Du X.L., Matsumura T., Edelstein D., Rossetti L., Zsuzsanna Z., Szabó C., and Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112 (2003) 1049-1057
13. Feener E.P., and King G.L. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail. Monit. 1 (2001) 74-82
14. Feldman E.L. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J. Clin. Invest. 111 (2003) 431-433
15. Fontaine E., Ichas F., and Bernardi P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 273 (1998) 25734-25740
16. 2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell. Signal. 18 (2006) 391-399
17. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
18. Kalén A., Appelkvist E.L., and Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids 24 (1989) 579-584
19. Kaliora A.C., Dedoussis G.V.Z., and Schmidt H. Dietary antioxidants in preventing atherosclerosis. Atherosclerosis 187 (2006) 1-17
20. King G.L., and Loeken M.R. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem. Cell Biol. 122 (2004) 333-338
21. Kouroedov A., Eto M., Joch H., Volpe M., Luscher T.F., and Cosentino F. Selective inhibition of protein kinase Cβ2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 110 (2004) 91-96
22. Liu B., Bhat M., and Nagaraj R.H. αB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochem. Biophys. Res. Commun. 321 (2004) 254-258
23. 10 sustained release tablets or regular tablets. Biol. Pharm. Bull. 26 (2003) 52-55
24. McDonnell M.G., and Archbold G.P. Plasma ubiquinol/cholesterol ratios in patients with hyperlipidaemia, those with diabetes mellitus and in patients requiring dialysis. Clin. Chim. Acta 253 (1996) 117-126
25. McLeod D.S., Lefer D.J., Merges C., and Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am. J. Pathol. 147 (1995) 642-653
26. 10 in diabetic patients. Arzneimittelforschung 49 (1999) 324-329
27. Newton A.C. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 370 (2003) 361-371
28. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
29. 10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J. Biol. Chem. 278 (2003) 28220-28228
30. Platt D.H., Bartoli M., El-Remessy A.B., Al-Shabrawey M., Lemtalsi T., Fulton D., and Caldwell R.B. Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Free Radic. Biol. Med. 39 (2005) 1353-1361
31. Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., Zuodar G., and Ceriello A. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183 (2005) 259-267
32. Quagliaro L., Piconi L., Assaloni R., Martinelli L., Mots E., and Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52 (2003) 2795-2804
33. Rask-Madsen C., and King G.L. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 487-496
34. Reusch J.E. Diabetes, microvascular complications, and cardiovascular complications: what is about glucose?. J. Clin. Invest. 112 (2003) 986-988
35. Risso A., Mercuri F., Quagliaro L., Damante G., and Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am. J. Physiol.: Endocrinol. Metab. 281 (2001) E924-E930
36. 10. J. Neurosci. Res. 72 (2003) 691-703
37. 10 and cardiovascular disease: a review. J. Cardiovasc. Nurs. 16 (2002) 9-20
38. Shen B.Q., Lee D.Y., and Zioncheck T.F. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J. Biol. Chem. 274 (1999) 33057-33063
39. Sheu M.L., Ho F.M., Yang R.S., Chao K.F., Lin W.W., Lin-Shiau S.Y., and Liu S.H. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 539-545
40. 10 in patients with Parkinson's disease. Exp. Neurol. 188 (2004) 491-494
41. 10. Neurobiol. Dis. 18 (2005) 618-627
42. Takami S., Yamashita S., Kihara S., Kameda-Takemura K., and Matsuzawa Y. High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis 138 (1998) 35-41
43. Tsuneki H., Ma E.-L., Kobayashi S., Sekizaki N., Maekawa K., Sasaoka T., Wang M.-W., and Kimura I. Antiangiogenic activity of β-eudesmol in vitro and in vivo. Eur. J. Pharmacol. 512 (2005) 105-115
44. Verrier E., Wang L., Wadham C., Albanese N., Hahn C., Gamble J.R., Chatterjee V.K., Vadas M.A., and Xia P. PPARγ agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. Circ. Res. 94 (2004) 1515-1522
45. Walford G.A., Moussignac R.L., Scribner A.W., Loscalzo J., and Leopold J.A. Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J. Biol. Chem. 279 (2004) 4925-4932
46. 10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 45 (2002) 420-426
47. Way K.J., Katai N., and King G.L. Protein kinase C and the development of diabetic vascular complications. Diabet. Med. 18 (2001) 945-959
48. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51 (2002) 198-203